This company listing is no longer active
METabolic EXplorer Future Growth
Future criteria checks 2/6
METabolic EXplorer's earnings are forecast to decline at 47.4% per annum while its annual revenue is expected to grow at 23.2% per year. EPS is expected to decline by 55.4% per annum. Return on equity is forecast to be 14.1% in 3 years.
Key information
-47.4%
Earnings growth rate
-55.4%
EPS growth rate
| Chemicals earnings growth | 16.5% |
| Revenue growth rate | 23.2% |
| Future return on equity | 14.1% |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 425 | 30 | -14 | 26 | 1 |
| 12/31/2023 | 357 | 12 | -16 | 25 | 1 |
| 12/31/2022 | 356 | 13 | 11 | 27 | 1 |
| 12/31/2021 | 172 | 84 | -11 | 4 | N/A |
| 9/30/2021 | 105 | 79 | -15 | 3 | N/A |
| 6/30/2021 | 38 | 75 | -19 | 1 | N/A |
| 3/31/2021 | 20 | 33 | -26 | -5 | N/A |
| 12/31/2020 | 2 | -9 | -34 | -11 | N/A |
| 9/30/2020 | 2 | -9 | -32 | -9 | N/A |
| 6/30/2020 | 2 | -8 | -30 | -8 | N/A |
| 3/31/2020 | 2 | -8 | -27 | -8 | N/A |
| 12/31/2019 | 2 | -8 | -24 | -8 | N/A |
| 9/30/2019 | 3 | -9 | -19 | -8 | N/A |
| 6/30/2019 | 3 | -9 | -13 | -7 | N/A |
| 3/31/2019 | 4 | -8 | -8 | -4 | N/A |
| 12/31/2018 | 6 | -6 | -3 | -1 | N/A |
| 9/30/2018 | 6 | -9 | -4 | -3 | N/A |
| 6/30/2018 | 7 | -11 | -6 | -5 | N/A |
| 3/31/2018 | 7 | -11 | -7 | -7 | N/A |
| 12/31/2017 | 7 | -11 | -9 | -9 | N/A |
| 9/30/2017 | 6 | -1 | 13 | 14 | N/A |
| 6/30/2017 | 6 | 8 | 35 | 36 | N/A |
| 3/31/2017 | 5 | 7 | 35 | 35 | N/A |
| 12/31/2016 | 4 | 7 | 34 | 35 | N/A |
| 9/30/2016 | 4 | 0 | 14 | 15 | N/A |
| 6/30/2016 | 4 | -7 | -6 | -5 | N/A |
| 3/31/2016 | 3 | -7 | -6 | -4 | N/A |
| 12/31/2015 | 3 | -7 | -6 | -4 | N/A |
| 9/30/2015 | 4 | -7 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: METEXP's earnings are forecast to decline over the next 3 years (-47.4% per year).
Earnings vs Market: METEXP's earnings are forecast to decline over the next 3 years (-47.4% per year).
High Growth Earnings: METEXP's earnings are forecast to decline over the next 3 years.
Revenue vs Market: METEXP's revenue (23.2% per year) is forecast to grow faster than the UK market (4% per year).
High Growth Revenue: METEXP's revenue (23.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: METEXP's Return on Equity is forecast to be low in 3 years time (14.1%).